Qimono QimoConnect

IV fluid bag extension set with a lateral injection site fitted with Qimo female

Dilution and administration of all kind of medications.

Clear
Commercial Code: N/A

About Product

Qimono the complete closed system for safe delivery of cytotoxic drugs

Stay safe with Qimono

It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .

Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .

Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.

Description of the device

QimoConnect is an extension tube with Qimo Female and Qimo Male ports for pharmacy drugs dilution and administration, with or without filter.

QimoConnect includes the following components:
– 1 spike,
– 1 Qimo Female needleless connector,
– 1 extension tube with clamp,
– 1 Qimo Male needleless connector which must be attached to the distal end of the extension tube after priming of QimoConnect,
– with or without filter ( see hereunder).

PE-lined tubing with external layer in PVC, intermediate layer in EVA and internal layer in PE (featuring chemical inertia and good chemical inertness to medications).

Codes 7221.01 / 7221.020*: QimoConnect
Codes 7221.011 / 7221.0110*: QimoConnect filter (0.2 µm) – See the corresponding technical file
Codes 7221.012 / 7221.0120*: QimoConnect air filter – See the corresponding technical file

Qimo Female is a multi-purpose, closed, needle-free, connection device. See the corresponding technical file code 7210.02.

Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. See the corresponding technical file code 7210.91.

Codes 7221.01 / 7221.011 / 7221.012: 1 unit in a supple blister.
Code 7221.020 / 7221.0110 / 7221.0120
– 7221.020: 10 units in a blister / 100 units in a box / 600 units in a case
– 7221.0110: 10 units in a blister / 100 units in a box / 600 units in a case
– 7221.0120: 10 units in a blister / 100 units in a box / 600 units in a case

* Codes 7221.020 / 7221.0110 / 7221.0120 are supplied without Qimo Male.

IV fluid bag extension set with a lateral injection site fitted with Qimo female .
Qimo male secures the distal end of the extension tube.

Composition of the device [description]
Components in contact with the solution:
– Spike in ABS
– Valve in MABS, SAN and silicone
– Internal layer tube in PE
– Male Luer-lock hub in ABS
– Y connector in PVC

Qimo Male
– Internal conduit in PBT and membrane in silicone
– Safety lock in PP
– Lubricant silicone

Qimo Female
– Tube in stainless steel
– Membrane in polyisoprene
– Male Luer-lock connector in PC
– Lubricant silicone

UOI Units: Box

Contains Latex: No

Contains DEHP: No

Pyrogen Free: Yes

Sterile Medical Device: Yes

Related Products

Product Support

Vygon is committed to education and support for our customers. We provide in-service training sessions for all staff and all shift patterns, to help ensure your clinicians achieve best practice when delivering care to patients. In addition, patient advice leaflets and children’s bravery certicates are available on request, to help assist the clinicians in supporting and informing their patients.

Supporting Documents Download:

Events

There are currently no related events to this product.

News

NIOSH Testing Success for Vygon’s CSTD Qimono

Tests to evaluate the effectiveness of closed system transfer devices (CSTD) in preventing exposure to dangerous chemotherapy drugs, has proven Vygon’s Qimono exceeds the rigorous NIOSH standards.

Read More

USP 800: A new standard of safety for US nurses

From 1st December this year American nurses handling hazardous drugs whilst treating cancer patients are legally protected by new standards covered by USP 800 guidelines.

Read More

Sact Safety Campaign Update

SACT Safety Campaign Update November 22nd 2019 Three years on from presenting their initial work into the safety risks facing …

Read More